Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: Israel Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20122
20151
20161
20171
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Not yet recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AbbVie1
AbbVie (prior sponsor, Abbott)1
Acerta Pharma BV1
Biogen1
Cellectar Biosciences, Inc.1
Genentech, Inc.1
Hoffmann-La Roche1
MedImmune LLC1
Sheba Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, Non-Hodgkin3
Lymphoma, Mantle-Cell2
Multiple Myeloma2
Neoplasms2
Recurrence2
Blood Protein Disorders1
Hematologic Diseases1
Hematologic Neoplasms1
Hodgkin Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.